X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA TORRENT PHARMA SHASUN PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 123.9 24.6 503.8% View Chart
P/BV x 8.5 6.0 141.7% View Chart
Dividend Yield % 0.2 3.3 7.0%  

Financials

 SHASUN PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TORRENT PHARMA
Mar-16
SHASUN PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs941,720 5.5%   
Low Rs461,134 4.0%   
Sales per share (Unadj.) Rs214.2394.5 54.3%  
Earnings per share (Unadj.) Rs5.3101.8 5.2%  
Cash flow per share (Unadj.) Rs15.8116.3 13.6%  
Dividends per share (Unadj.) Rs1.0040.00 2.5%  
Dividend yield (eoy) %1.42.8 51.0%  
Book value per share (Unadj.) Rs53.3200.3 26.6%  
Shares outstanding (eoy) m56.62169.22 33.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.6 9.0%   
Avg P/E ratio x13.114.0 93.5%  
P/CF ratio (eoy) x4.412.3 36.0%  
Price / Book Value ratio x1.37.1 18.4%  
Dividend payout %18.739.3 47.7%   
Avg Mkt Cap Rs m3,958241,435 1.6%   
No. of employees `000NA10.9 0.0%   
Total wages/salary Rs m2,1648,559 25.3%   
Avg. sales/employee Rs ThNM6,129.6-  
Avg. wages/employee Rs ThNM785.8-  
Avg. net profit/employee Rs ThNM1,581.3-  
INCOME DATA
Net Sales Rs m12,12766,764 18.2%  
Other income Rs m2292,156 10.6%   
Total revenues Rs m12,35668,920 17.9%   
Gross profit Rs m1,00927,204 3.7%  
Depreciation Rs m5942,461 24.1%   
Interest Rs m4151,859 22.3%   
Profit before tax Rs m23025,041 0.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m-736,414 -1.1%   
Profit after tax Rs m30217,224 1.8%  
Gross profit margin %8.340.7 20.4%  
Effective tax rate %-31.725.6 -123.6%   
Net profit margin %2.525.8 9.7%  
BALANCE SHEET DATA
Current assets Rs m6,88446,622 14.8%   
Current liabilities Rs m8,45632,843 25.7%   
Net working cap to sales %-13.020.6 -62.8%  
Current ratio x0.81.4 57.4%  
Inventory Days Days6274 83.0%  
Debtors Days Days10879 136.1%  
Net fixed assets Rs m4,97039,029 12.7%   
Share capital Rs m113846 13.4%   
"Free" reserves Rs m2,87531,400 9.2%   
Net worth Rs m3,02033,890 8.9%   
Long term debt Rs m1,81718,637 9.8%   
Total assets Rs m13,34790,136 14.8%  
Interest coverage x1.614.5 10.7%   
Debt to equity ratio x0.60.5 109.4%  
Sales to assets ratio x0.90.7 122.7%   
Return on assets %5.421.2 25.4%  
Return on equity %10.050.8 19.7%  
Return on capital %13.348.5 27.4%  
Exports to sales %46.443.3 107.0%   
Imports to sales %14.26.9 207.5%   
Exports (fob) Rs m5,62228,934 19.4%   
Imports (cif) Rs m1,7284,584 37.7%   
Fx inflow Rs m5,84329,185 20.0%   
Fx outflow Rs m2,1736,021 36.1%   
Net fx Rs m3,66923,165 15.8%   
CASH FLOW
From Operations Rs m39827,132 1.5%  
From Investments Rs m-1,635-7,014 23.3%  
From Financial Activity Rs m1,309-14,352 -9.1%  
Net Cashflow Rs m715,767 1.2%  

Share Holding

Indian Promoters % 39.2 71.5 54.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 7.0 51.3%  
FIIs % 17.6 12.6 139.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 8.8 450.0%  
Shareholders   20,750 26,511 78.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS